Role of miR-424 in the carcinogenesis

S Ghafouri-Fard, A Askari, BM Hussen, M Taheri… - Clinical and …, 2024 - Springer
Recent studies have revealed the impact of microRNAs (miRNAs) in the carcinogenic
process. miR-424 is a miRNA whose role in this process is being to be identified …

The role and interactions of programmed cell death 4 and its regulation by microRNA in transformed cells of the gastrointestinal tract

WF Ferris - Frontiers in Oncology, 2022 - frontiersin.org
Data from GLOBOCAN 2020 estimates that there were 19.3 million new cases of cancer and
10.0 million cancer-related deaths in 2020 and that this is predicted to increase by 47% in …

MiRNA-424-5p suppresses proliferation, migration, and invasion of clear cell renal cell carcinoma and attenuates expression of O-GlcNAc-Transferase

TJ Kalantzakos, TB Sullivan, T Gloria, D Canes… - Cancers, 2021 - mdpi.com
Simple Summary The identification of biomarkers that predict the metastatic potential of
tumors is a current area of interest in cancer research. A previous study from our laboratory …

Integrated Analysis of Ulcerative Colitis Revealed an Association between PHLPP2 and Immune Infiltration

T Li, W Liu, W Hui, T Shi, H Liu, Y Feng… - Disease …, 2022 - Wiley Online Library
Ulcerative colitis (UC) is a progressive intestine inflammatory disease that is prone to recur.
Herein, we utilize microarray technology and bioinformatics to reveal the underlying …

[HTML][HTML] Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN/PI3K/AKT signaling pathway

Y Lu, Q Lin, C Lin, J Chen, X Jiang, H He - Journal of Cancer, 2023 - ncbi.nlm.nih.gov
Background: The incidence of endometrial carcinoma (EC) has been increasing annually,
and treatment of advanced cases remains challenging. MicroRNA-424 (miR-424) was …

Exosomal mirnas as possible predictors of immune checkpoint inhibitors therapy response in clear cell renal cell carcinoma

IR Gilyazova, DD Asadullina… - Molekulyarnaya …, 2023 - journals.eco-vector.com
Despite significant advance in clear cell renal cell carcinoma treatment, immune checkpoint
inhibitors (ICIs) still have limited therapeutic efficacy. Taking into account the resistance to …